Longitudinal changes in peritoneal solute transport rate and the impact of lower glucose degradation product glucose dialysates
- PMID: 40129079
- PMCID: PMC12050142
- DOI: 10.1111/1744-9987.70012
Longitudinal changes in peritoneal solute transport rate and the impact of lower glucose degradation product glucose dialysates
Abstract
Introduction: Peritoneal solute transfer rates (PSTR) are reported to increase with time. Changes in PSTR were reviewed in long-term peritoneal dialysis (PD) patients to determine whether lower glucose degradation products (low GDP) dialysates prevented an increase in PSTR.
Methods: PSTR was determined with a 4-h peritoneal equilibrium test with a 2.0 L 22.7 g/L glucose dialysate.
Results: One hundred twenty-three PD patients treated for ≥4 years, 47.2% male, age 61 ± 16 years, 31.7% diabetic. Initially, 15.6% were treated with low GDP dialysates, which rose to 44.7% at 6 years. Creatinine PSTR increased with standard glucose dialysates (0.72 ± 0.1 at Year 3 to 0.79 ± 0.1 Year 5 and 0.82 ± 0.1 Year 6, p < 0.05), whereas PSTR was stable and lower with low GDP dialysates (0.71 ± 0.1, 0.65 ± 0.1, 0.68 ± 0.1); p < 0.001 for Years 5 and 6.
Conclusion: Exposure to standard glucose dialysates resulted in faster peritoneal solute transfer rates over time, whereas peritoneal solute transfer rates appeared more stable with lower glucose degradation products dialysates.
Keywords: bioimpedance; end stage kidney disease; glucose degradation products; icodextrin; peritoneal dialysis; peritoneal solute transport rate.
© 2025 The Author(s). Therapeutic Apheresis and Dialysis published by John Wiley & Sons Australia, Ltd on behalf of International Society for Apheresis and Japanese Society for Apheresis.
Conflict of interest statement
The author has any conflicts of interest or competing interests.
Figures


Similar articles
-
Peritoneal equilibration test with conventional 'low pH/high glucose degradation product' or with biocompatible 'normal pH/low glucose degradation product' dialysates: does it matter?Nephrol Dial Transplant. 2013 Jul;28(7):1946-51. doi: 10.1093/ndt/gfs433. Epub 2012 Dec 6. Nephrol Dial Transplant. 2013. PMID: 23223220
-
Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis.Perit Dial Int. 2006 Jan-Feb;26(1):53-63. Perit Dial Int. 2006. PMID: 16538876
-
Contribution of residual renal function on peritoneal solute transport in dialysis patients.Am J Nephrol. 2010;32(3):187-193. doi: 10.1159/000316971. Epub 2010 Jul 15. Am J Nephrol. 2010. PMID: 20639626
-
Biocompatible dialysis fluids for peritoneal dialysis.Cochrane Database Syst Rev. 2018 Oct 26;10(10):CD007554. doi: 10.1002/14651858.CD007554.pub3. Cochrane Database Syst Rev. 2018. PMID: 30362116 Free PMC article.
-
Peritoneal solute transport and inflammation.Am J Kidney Dis. 2014 Dec;64(6):978-86. doi: 10.1053/j.ajkd.2014.06.030. Epub 2014 Aug 29. Am J Kidney Dis. 2014. PMID: 25176170 Review.
References
-
- Elphick E, Holmes M, Tabinor M, Cho Y, Nguyen T, Harris T, et al. Outcome measures for technique survival reported in peritoneal dialysis: a systematic review. Perit Dial Int. 2022;42(3):279–287. - PubMed
-
- Öberg CM. Optimization of bimodal automated peritoneal dialysis prescription using the three‐pore model. Perit Dial Int. 2021;41(4):381–393. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical